Bridging the gap between cytotoxic and biologic therapy with metronomic topotecan and pazopanib in ovarian cancer

To investigate the anti-tumor and anti-angiogenic effects utilizing a novel therapy regimen of metronomic topotecan and pazopanib, a multi-receptor tyrosine kinase inhibitor. In vitro (Western blot) and in vivo dose-finding experiments were performed following pazopanib therapy in ovarian cancer mod...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Merritt, William M., Nick, Alpa M., Carroll, Amy R., Lu, Chunhua, Matsuo, Koji, Dumble, Melissa, Jennings, Nicholas, Zhang, ShuYun, Lin, Yvonne G., Spannuth, Whitney A., Kamat, Aparna A., Stone, Rebecca L., Shahzad, Mian M.K., Coleman, Robert L., Kumar, Rakesh, Sood, Anil K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2852465/
https://ncbi.nlm.nih.gov/pubmed/20371710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-09-0967
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados